SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027759
Filing Date
2018-11-07
Accepted
2018-11-07 09:01:26
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20180930.htm 10-Q 1838738
2 EX-31.1 mack-ex311_10.htm EX-31.1 9563
3 EX-31.2 mack-ex312_8.htm EX-31.2 9512
4 EX-32.1 mack-ex321_6.htm EX-32.1 5737
5 EX-32.2 mack-ex322_7.htm EX-32.2 5673
  Complete submission text file 0001564590-18-027759.txt   6428546

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20180930.xml EX-101.INS 1345599
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20180930.xsd EX-101.SCH 45245
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20180930_cal.xml EX-101.CAL 68299
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20180930_def.xml EX-101.DEF 164391
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20180930_lab.xml EX-101.LAB 379747
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20180930_pre.xml EX-101.PRE 290102
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 181164871
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1